MAPT and Alzheimer disease: Secondly, we had no information regarding the amyloid and tau status and amyloid positron emission tomography imaging of our participants and were thus unable to assess the influence of these AD biomarkers on the relationship between WMH and brain structure, and between cortical atrophy and WMH volume.